Table 3.
Outcome of patients treated for seminoma from 1999 to 2008 [22]
| Stage | Treatment | Number of patients | 5-Year relapse rate (%) | Second relapse, n | 5-Year disease-specific survival (%) | 5-Year overall survival (%) | Dead of disease/treatment, n (%) | Death other cause, n (%) |
|---|---|---|---|---|---|---|---|---|
| Surv | 313 | 19.3 | 3a (1%) | 100 | 99 | 0 | 2 (1) | |
| I | RT | 159 | 2 | 0 | 100 | 99.3 | 0 | 1 (1) |
| Carb | 73 | 2 | 0 | 100 | 100 | 0 | 0 | |
| RT | 19 | 8.3 | 0 | 100 | 92.3 | 0 | 1 (3) | |
| II | CHT | 65 | 4.5 | 0 | 100 | 90.7 | 3 (5%) | 2 (3) |
| Other | 3 | 0 | 0 | 100 | 100 | 0 | 0 | |
| III | CHT | 17 | 0 | 0 | 100 | 100 | 0 | 0 |
a: After RT for first relapse.
Carb, single-agent carboplatin; CHT, primary combination chemotherapy; Other, other treatment modalities or combination of treatment modalities; RT, radiation; Surv, surveillance.